• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Oppenheimer initiated coverage on Harpoon Therapeutics with a new price target

    1/5/24 8:28:33 AM ET
    $HARP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $HARP alert in real time by email
    Oppenheimer initiated coverage of Harpoon Therapeutics with a rating of Outperform and set a new price target of $23.00
    Get the next $HARP alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HARP

    DatePrice TargetRatingAnalyst
    1/5/2024$23.00Outperform
    Oppenheimer
    11/20/2023Outperform
    TD Cowen
    7/6/2022$16.00Buy
    Canaccord Genuity
    11/11/2021$25.00 → $19.00Outperform
    SVB Leerink
    9/28/2021$16.00Neutral → Buy
    Citigroup
    8/6/2021$29.00 → $25.00Outperform
    SVB Leerink
    More analyst ratings